Yixintang Pharmaceutical Group Co., Ltd. (SHE:002727)
China · Delayed Price · Currency is CNY 11.79
+0.12 (1.03%)
Aug 3, 2026, 3:04 PM CST
SHE:002727 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Equivalents | 2,547 | 2,302 | 3,418 | 3,676 | 3,512 | 2,235 |
Short-Term Investments | - | - | - | 219.66 | - | - |
Trading Asset Securities | 749.88 | 759.84 | - | - | 8.36 | 297.3 |
Cash & Short-Term Investments | 3,297 | 3,062 | 3,418 | 3,895 | 3,520 | 2,532 |
Cash Growth | -4.39% | -10.40% | -12.26% | 10.66% | 39.00% | -17.16% |
Accounts Receivable | 1,643 | 1,563 | 1,613 | 1,555 | 1,776 | 1,376 |
Other Receivables | 296.54 | 312.22 | 319.49 | 313.3 | 307.29 | 206.63 |
Receivables | 1,940 | 1,875 | 1,932 | 1,868 | 2,083 | 1,583 |
Inventory | 3,673 | 3,673 | 4,088 | 3,853 | 3,387 | 3,317 |
Prepaid Expenses | - | 1.03 | 3.49 | 1.03 | 0.14 | 0.16 |
Other Current Assets | 316.38 | 335.68 | 270.29 | 275.63 | 467.06 | 260.12 |
Total Current Assets | 9,226 | 8,947 | 9,712 | 9,893 | 9,458 | 7,692 |
Property, Plant & Equipment | 3,392 | 3,574 | 3,956 | 3,951 | 3,994 | 4,080 |
Long-Term Investments | 140.4 | 131.4 | 136.52 | 143.26 | 352.46 | 107.22 |
Goodwill | 1,961 | 1,961 | 1,983 | 1,650 | 1,397 | 1,380 |
Other Intangible Assets | 274.68 | 277.08 | 196.86 | 178.08 | 165.67 | 122.89 |
Long-Term Deferred Tax Assets | 101.51 | 102.04 | 93.7 | 88.94 | 94.11 | 58.46 |
Long-Term Deferred Charges | 536.46 | 556.44 | 724.03 | 661.17 | 629.9 | 590.75 |
Other Long-Term Assets | 53.4 | 58.69 | 29 | 82.31 | 88.59 | 305.71 |
Total Assets | 15,685 | 15,608 | 16,830 | 16,647 | 16,179 | 14,337 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Accounts Payable | 4,454 | 4,436 | 4,916 | 4,339 | 4,329 | 3,806 |
Accrued Expenses | 227.99 | 460.29 | 539.54 | 681.48 | 518.75 | 295.38 |
Short-Term Debt | 534.41 | 538.78 | 503.76 | 468.6 | 402.57 | 127.7 |
Current Portion of Long-Term Debt | - | - | - | 1.8 | 0.2 | 4.02 |
Current Portion of Leases | 824.34 | 851 | 1,005 | 975.88 | 932.77 | 1,012 |
Current Income Taxes Payable | 136.98 | 56.56 | 53.62 | 81.37 | 197.86 | 118.4 |
Current Unearned Revenue | 141.01 | 110.6 | 116.9 | 113.72 | 156.61 | 105.18 |
Other Current Liabilities | 541.51 | 411.2 | 496.42 | 537.55 | 339.23 | 415.09 |
Total Current Liabilities | 6,861 | 6,864 | 7,631 | 7,200 | 6,877 | 5,884 |
Long-Term Debt | - | - | - | - | 1.8 | 35.08 |
Long-Term Leases | 1,169 | 1,266 | 1,531 | 1,552 | 1,757 | 1,729 |
Long-Term Unearned Revenue | 17.35 | 16.29 | 11.55 | 14.54 | 12.15 | 13.34 |
Long-Term Deferred Tax Liabilities | 3.22 | 3.3 | 3.55 | 3.93 | 4.05 | 3.56 |
Total Liabilities | 8,050 | 8,150 | 9,177 | 8,770 | 8,652 | 7,665 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Common Stock | 585.6 | 585.6 | 585.6 | 596.01 | 596.02 | 596.18 |
Additional Paid-In Capital | 2,013 | 2,013 | 2,019 | 2,144 | 2,147 | 2,157 |
Retained Earnings | 5,039 | 4,863 | 4,886 | 5,011 | 4,700 | 3,869 |
Treasury Stock | -150 | -150 | - | -4.24 | -22.69 | -46.86 |
Comprehensive Income & Other | -8.55 | -8.55 | - | - | 6.19 | 2.93 |
Total Common Equity | 7,479 | 7,303 | 7,491 | 7,746 | 7,426 | 6,578 |
Minority Interest | 155.86 | 153.84 | 162.27 | 131.04 | 101.44 | 94.8 |
Shareholders' Equity | 7,635 | 7,457 | 7,653 | 7,877 | 7,528 | 6,673 |
Total Liabilities & Equity | 15,685 | 15,608 | 16,830 | 16,647 | 16,179 | 14,337 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Total Debt | 2,527 | 2,656 | 3,039 | 2,998 | 3,094 | 2,908 |
Net Cash (Debt) | 769.21 | 406.14 | 378.39 | 896.84 | 425.94 | -375.58 |
Net Cash Growth | 114.52% | 7.34% | -57.81% | 110.56% | - | - |
Net Cash Per Share | 1.34 | 0.70 | 0.64 | 1.50 | 0.72 | -0.63 |
Filing Date Shares Outstanding | 574.13 | 574.13 | 585.6 | 596.01 | 596.02 | 596.18 |
Total Common Shares Outstanding | 574.13 | 574.13 | 585.6 | 596.01 | 596.02 | 596.18 |
Working Capital | 2,365 | 2,082 | 2,080 | 2,693 | 2,581 | 1,809 |
Book Value Per Share | 13.03 | 12.72 | 12.79 | 13.00 | 12.46 | 11.03 |
Tangible Book Value | 5,243 | 5,065 | 5,311 | 5,918 | 5,863 | 5,075 |
Tangible Book Value Per Share | 9.13 | 8.82 | 9.07 | 9.93 | 9.84 | 8.51 |
Buildings | - | 916.42 | 892.7 | 894.92 | 785.07 | 741.03 |
Machinery | - | 465.66 | 447.47 | 416.9 | 385.35 | 350.85 |
Construction In Progress | - | 165.2 | 35.79 | 9.81 | 3.87 | 25.47 |